Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Interest Expenses: 2009-2024

Historic Interest Expenses for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $605,508.

  • Cumberland Pharmaceuticals' Interest Expenses fell 20.15% to $109,699 in Q3 2025 from the same period last year, while for Sep 2025 it was $606,309, marking a year-over-year increase of 8.07%. This contributed to the annual value of $605,508 for FY2024, which is 9.34% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Interest Expenses stood at $605,508 for FY2024, which was down 9.34% from $667,861 recorded in FY2023.
  • Cumberland Pharmaceuticals' Interest Expenses' 5-year high stood at $667,861 during FY2023, with a 5-year trough of $98,031 in FY2021.
  • For the 3-year period, Cumberland Pharmaceuticals' Interest Expenses averaged around $619,788, with its median value being $605,508 (2024).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Interest Expenses plummeted by 62.81% in 2021 and then skyrocketed by 497.76% in 2022.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Interest Expenses stood at $263,627 in 2020, then crashed by 62.81% to $98,031 in 2021, then soared by 497.76% to $585,995 in 2022, then climbed by 13.97% to $667,861 in 2023, then decreased by 9.34% to $605,508 in 2024.